| P0013-0001 | Paroxetine Acetate | 72471-80-8 | Related substance |
| P0013-0004 | Paroxetine Hydrochloride | 78246-49-8 | Salt / salt form |
| P0013-0006 | Paroxetine Maleate | 64006-44-6 | Salt / salt form |
| P0013-0008 | Paroxetine Mesylate | 217797-14-3 | Salt / salt form |
| P0013-0009 | Paroxetine oxalate salt | 1435728-63-4 | Related substance |
| P0013-0012 | Paroxetine EP Impurity A Hydrochloride | 1394842-91-1 | Impurity |
| P0013-0019 | Rel-Paroxetine hydrochloride hemihydrate EP Impurity B HCl | 127017-74-7 | Impurity |
| P0013-0022 | Paroxetine EP Impurity C HCl | 105813-13-6 | Impurity |
| P0013-0032 | Paroxetine impurity D (Y0000256) | 130855-30-0 | Impurity |
| P0013-0044 | Paroxetine EP Impurity H | 503834-41-1 | Impurity |
| P0013-0050 | Paroxetine EP Impurity J | 28-22-8 | Impurity |
| P0013-0067 | Paroxetine Impurity 4 | 324023-99-6 | Impurity |
| P0013-0069 | Paroxetine Impurity 5 | 100332-20-5 | Impurity |
| P0013-0070 | Paroxetine Hydrochloride Impurity 6 | 253768-88-6 | Impurity |
| P0013-0071 | Paroxetine Impurity 6 | 100332-12-5 | Impurity |
| P0013-0075 | Paroxetine Hydrochloride Impurity 8 | 176022-03-0 | Impurity |
| P0013-0087 | Paroxetine Hydrochloride Impurity 16 | 1217655-87-2 | Impurity |
| P0013-0101 | Paroxetine Impurity 31 | 2105932-71-4 | Impurity |
| P0013-0105 | Paroxetine Hydrochloride Impurity 34 Monomer | 617-97-0 | Impurity |
| P0013-0115 | Paroxetine Hydrochloride Impurity 45 Hydrochloride-d4 | 1217753-24-6 | Impurity |
| P0013-0116 | Paroxetine Hydrochloride Impurity 46 Hydrochloride | 105813-04-5 | Impurity |
| P0013-0118 | Paroxetine Hydrochloride Impurity 58 | 459-57-4 | Impurity |
| P0013-0119 | Paroxetine Hydrochloride Impurity 59 | 71510-95-7 | Impurity |
| P0013-0129 | Paroxetine Hydrochloride Impurity 74 | 127017-78-1 | Impurity |
| P0013-0131 | Paroxetine Hydrochloride Impurity 75 | 127017-41-8 | Impurity |
| P0013-0133 | Paroxetine Hydrochloride Impurity 79 | 2512204-89-4 | Impurity |
| P0013-0135 | Paroxetine Hydrochloride Impurity 83 | 1394861-12-1 | Impurity |
| P0013-0136 | Paroxetine Hydrochloride Impurity 84 | 112058-89-6 | Impurity |
| P0013-0137 | Paroxetine Hydrochloride Impurity 86 | 112058-90-9 | Impurity |
| P0013-0138 | Paroxetine Hydrochloride Impurity 87 | 1292846-10-6 | Impurity |
| P0013-0139 | Paroxetine Hydrochloride Impurity 88 | 1544-85-0 | Impurity |
| P0013-0140 | Paroxetine Hydrochloride Impurity 89 | 2635-13-4 | Impurity |
| P0013-0141 | Paroxetine Hydrochloride Impurity 103 | 18830-99-4 | Impurity |
| P0013-0154 | Paroxetine Impurity 150 | 127017-42-9 | Impurity |
| P0013-0160 | Paroxetine Impurity 161 | 606968-04-1 | Impurity |
| P0013-0168 | Paroxetine Impurity 171 | 200114-09-6 | Impurity |
| P0013-0169 | Paroxetine Impurity 172 | 116147-95-6 | Impurity |
| P0013-0174 | Paroxetine D4Q: What is Paroxetine D4 Q: What is the CAS Number of Paroxetine D4 | 1217976-29-8 | Stable-isotope labelled analogue |
| P0013-0175 | Paroxetine Hydrochloride-d4 | 1217683-35-6 | Stable-isotope labelled analogue |
| P0013-0197 | ((3R,4S)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl)methyl acetate | 923932-21-2 | Related substance |
| P0013-0201 | ((3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl methanesulfonate | 608521-21-7 | Related substance |
| P0013-0209 | (+/-)-TRANS-4-(FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINE | 318279-38-8 | Related substance |
| P0013-0210 | (1-(benzo[d][1,3]dioxol-5-yl)ethylidene)hydrazine | 1257974-55-2 | Related substance |
| P0013-0216 | (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine | 72473-26-8 | Related substance |
| P0013-0217 | (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine | 105813-05-6 | Related substance |
| P0013-0222 | (3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl) piperidine | 112058-85-2 | Related substance |
| P0013-0225 | (3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine | 3060802-35-6 | Related substance |
| P0013-0226 | (3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl-13C)-4-(4-fluorophenyl)-1-methylpiperidine | 153779-99-8 | Stable-isotope labelled analogue |
| P0013-0227 | (3R,4S)-N-Methyl Paroxetine | 2575750-19-3 | Related substance |
| P0013-0229 | (3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine-d4 Hydrochloride | 2124277-97-8 | Stable-isotope labelled analogue |
| P0013-0231 | (3S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine | 1322626-23-2 | Related substance |
| P0013-0238 | (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-benzyl-4-phenylpiperidine | 105813-40-9 | Related substance |
| P0013-0249 | (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidin-1-ol | 2265884-79-3 | Related substance |
| P0013-0254 | (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine Formate | 236391-42-7 | Related substance |
| P0013-0259 | (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-ethoxyphenyl)piperidine | 1346597-97-4 | Related substance |
| P0013-0260 | (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)-1-methylpiperidine | 110429-36-2 | Related substance |
| P0013-0264 | (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-Phenylpiperidine | 324024-00-2 | Related substance |
| P0013-0265 | (3S,4R)-3-[(6-chloro-1,3-benzodioxol-5-yl)oxymethyl]-4-(4-fluorophenyl)piperidine | 1243647-61-1 | Related substance |
| P0013-0266 | (3S,4R)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol Tosylate | 317323-77-6 | Related substance |
| P0013-0275 | (3S,4S)-N-Methyl Paroxetine | 23-17-6 | Related substance |
| P0013-0276 | (4-Methoxyphenyl)(4-(4-methoxyphenyl)-1-methylpiperidin-3-yl)methanol | 10185-04-3 | Related substance |
| P0013-0281 | (S)-4-(4-fluorophenyl)-1-methyl-3-methylenepiperidine | 477788-80-0 | Related substance |
| P0013-0283 | 1(2H)-Pyridinecarboxylic acid, 3,6-dihydro-5-(hydroxymethyl)-4-(4-methoxyphenyl)-, 1,1-dimethylethyl ester | 2088564-24-1 | Related substance |
| P0013-0285 | 1,3(2H)-Pyridinedicarboxylic acid, 4-(4-fluorophenyl)-5,6-dihydro-, 1-(1,1-dimethylethyl) 3-ethyl ester | 455954-86-6 | Related substance |
| P0013-0286 | 1,3(2H)-Pyridinedicarboxylic acid, 5,6-dihydro-4-(4-methoxyphenyl)-, 1-(1,1-dimethylethyl) 3-ethyl ester | 1432676-46-4 | Related substance |
| P0013-0287 | 1,3-benzodioxol-5-amine | 14268-66-7 | Related substance |
| P0013-0288 | 1,3-benzodioxol-5-yl acetate | 326-58-9 | Related substance |
| P0013-0289 | 1,3-benzodioxole | 274-09-9 | Related substance |
| P0013-0291 | 1-(1,3-benzodioxol-5-yl)ethanone | 3162-29-6 | Related substance |
| P0013-0294 | 1-(Tert-butyl) 3-ethyl (3R,4R)-4-(4-methoxyphenyl)piperidine-1,3-dicarboxylate | 202534-94-9 | Related substance |
| P0013-0299 | 1-benzyl-4-(4-fluorophenyl)-3,6-dihydro-2H-pyridine | 163630-89-5 | Related substance |
| P0013-0300 | 1-benzyl-4-(4-fluorophenyl)piperidin-4-ol | 163631-02-5 | Related substance |
| P0013-0302 | 1-benzyl-4-methylpiperidin-3-ol | 384338-20-9 | Related substance |
| P0013-0303 | 1-Chloroethyl (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate | 389573-45-9 | Related substance |
| P0013-0305 | 1-Piperidinecarboxylic acid, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, 1,1-dimethylethyl ester, (3R,4S) | 179179-81-8 | Related substance |
| P0013-0306 | 1-Piperidinecarboxylic acid, 4-(4-fluorophenyl)-3-[[(methylsulfonyl)oxy]methyl]-, 1,1-dimethylethyl ester, (3S,4R) | 200572-34-5 | Related substance |
| P0013-0307 | 1-TERT-BUTYL 3-ETHYL 4-(TRIFLUOROMETHYLSULFONYLOXY)-5,6-DIHYDROPYRIDINE-1,3(2H)-DICARBOXYLATE | 176525-98-7 | Related substance |
| P0013-0309 | 2-chloroethyl (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate | 592516-96-6 | Related substance |
| P0013-0312 | 3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride | 1193389-61-5 | Salt / salt form |
| P0013-0313 | 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine | 2990987-89-6 | Related substance |
| P0013-0316 | 3-(4-FLUOROPHENYL)BENZALDEHYDE | 164334-74-1 | Related substance |
| P0013-0318 | 3-Piperidinecarboxylic acid, 4-(4-fluorophenyl)-1-methyl-2,6-dioxo-, methyl ester, trans-(±) | 153173-08-1 | Related substance |
| P0013-0319 | 3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, 3-methanesulfonate, (3R,4S)- | 477788-78-6 | Related substance |
| P0013-0321 | 4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine | 1978-59-2 | Related substance |
| P0013-0322 | 4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine | 1978-61-6 | Related substance |
| P0013-0324 | 4-(4-Fluorophenyl)-1-methylpiperidin-4-ol | 36882-06-1 | Related substance |
| P0013-0326 | 4-(4-Fluorophenyl)-3-hydroxymethyl-1-methyl-piperidine | 109887-53-8 | Related substance |
| P0013-0328 | 4-[[(3S,4R)-4-(4-Fluorophenyl)-3-piperidinyl]methoxy]-1,2-benzenediol | 159126-30-4 | Related substance |
| P0013-0331 | 6-Chlorobenzo[d][1,3]dioxol-5-ol | 105607-67-8 | Related substance |
| P0013-0332 | [(3R,4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methyl 4-methylbenzenesulfonate | 1258537-32-4 | Related substance |
| P0013-0333 | [(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methanol | 105812-81-5 | Related substance |
| P0013-0337 | bis(6-((4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzo[d][1,3]dioxol-5-yl)methane | 606968-05-2 | Related substance |
| P0013-0338 | Cis-Paroxetine | 105813-07-8 | Related substance |
| P0013-0339 | Defluoro Paroxetine Hydrochloride | 130777-04-7 | Salt / salt form |
| P0013-0341 | Ethyl (3R,4S)-3-(acetoxymethyl)-4-phenylpiperidine-1-carboxylate | 200572-33-4 | Related substance |
| P0013-0343 | Ethyl 3-(4-Fluorophenyl)acrylate | 352-03-4 | Related substance |
| P0013-0345 | Methanol, ((3S,4R)-4-(4-ethoxyphenyl)-1-methylpiperidin-3-yl) | 533-31-3 | Related substance |
| P0013-0347 | Methyl 4-(4-fluorophenyl)-1-methyl-2,6-dioxo-3-piperidinecarboxylate | 1558726-44-5 | Related substance |
| P0013-0354 | N-Nitroso paroxetine Impurity | 2361294-43-9 | Impurity |
| P0013-0367 | Paroxetine Methoxy Analog (R,S) Isomer | 3060802-36-7 | Isomer |
| P0013-0377 | Paroxetine Related Compound F ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylp (1500273) | 1217676-35-1 | Related compound |
| P0013-0384 | Paroxetine-d4 HCl | 2714485-95-5 | Stable-isotope labelled analogue |
| P0013-0390 | PAROXETINE-D6 MALEATE | 1435728-64-5 | Stable-isotope labelled analogue |
| P0013-0392 | Phenyl (3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate | 130777-05-8 | Related substance |
| P0013-0396 | Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4′-fluoro[1,1′-biphenyl]-4-yl)-, (3R,4S)-rel- | 1217975-87-5 | Related substance |
| P0013-0399 | rac-4-Ethoxy Paroxetine hydrochloride Salt | 2990987-84-1 | Salt / salt form |
| P0013-0400 | rac-N-Methyl Paroxetine | 315197-83-2 | Related substance |
| P0013-0408 | Tetrahydro-2H-pyran-3,4,5-triol, 2-((6-((3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidin-1-yl)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl) | 112058-87-4 | Related substance |
| P0013-0409 | trans 1-Benzyl-4-(4-fluorophenyl)-3-piperidinemethanol | 201855-60-9 | Related substance |
| P0013-0410 | trans N-Benzyl Paroxetine | 105813-14-7 | Related substance |
| P0013-0411 | trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-ethoxyphenyl)piperidine | 1395408-54-4 | Related substance |
| P0013-0413 | trans-3-Ethoxycarbonyl-4-(4-flurophenyl)-N-methyl piperdine-2,6-dione | 109887-52-7 | Related substance |
| P0013-0414 | Paroxetine Impurity 1 | 1012886-75-7 | Impurity |
| P0013-0415 | Paroxetine Impurity 1 | 69675-10-1 | Impurity |
| P0013-0416 | Paroxetine Impurity 10 | 1396174-70-1 | Impurity |
| P0013-0426 | Paroxetine Impurity 15 | 3060802-38-9 | Impurity |
| P0013-0427 | Paroxetine Impurity 15 | 3060802-37-8 | Impurity |
| P0013-0430 | Paroxetine Impurity 4 | 125224-43-3 | Impurity |
| P0013-0431 | Paroxetine Impurity 4 | 220548-73-2 | Impurity |
| P0013-0432 | Paroxetine Impurity 5 | 105813-39-6 | Impurity |